HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory J Dore Selected Research

sofosbuvir velpatasvir voxilaprevir drug combination

5/2022Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
1/2017Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory J Dore Research Topics

Disease

144Infections
11/2022 - 05/2000
50Hepatitis C
01/2022 - 07/2005
39Fibrosis (Cirrhosis)
05/2022 - 03/2005
32Coinfection
01/2020 - 10/2003
31Chronic Hepatitis C
01/2022 - 10/2003
24Reinfection
11/2022 - 10/2009
22Liver Diseases (Liver Disease)
01/2020 - 12/2007
11HIV Infections (HIV Infection)
02/2016 - 12/2003
11Hepatitis B
09/2014 - 07/2004
9Hepatocellular Carcinoma (Hepatoma)
12/2021 - 03/2005
8Disease Progression
01/2019 - 10/2003
7Hepatitis
01/2020 - 05/2004
5Virus Diseases (Viral Diseases)
01/2020 - 05/2011
5Liver Cirrhosis (Hepatic Cirrhosis)
10/2019 - 09/2008
5Acquired Immunodeficiency Syndrome (AIDS)
01/2011 - 04/2002
4Chronic Hepatitis B
12/2020 - 01/2010
4Blister (Bulla)
10/2020 - 01/2018
4Viremia
01/2019 - 10/2010
3COVID-19
08/2022 - 01/2021
3Communicable Diseases (Infectious Diseases)
12/2021 - 01/2017
3Neoplasms (Cancer)
01/2018 - 05/2009
3Persistent Infection
01/2017 - 09/2014
2Substance-Related Disorders (Drug Abuse)
12/2021 - 01/2021
2Inflammation (Inflammations)
01/2019 - 01/2016
2Nausea
12/2018 - 01/2017
2Liver Neoplasms (Liver Cancer)
01/2018 - 05/2009
2Headache (Headaches)
01/2017 - 08/2014
2Fatigue
01/2017 - 08/2014
2Anemia
06/2014 - 04/2011
2Superinfection
04/2012 - 11/2010
2AIDS Dementia Complex
07/2003 - 04/2002
1Cellulitis
01/2022
1Abscess
01/2022
1Opioid-Related Disorders (Opiate Addiction)
01/2022
1Alcoholism (Alcohol Abuse)
12/2021
1Portal Hypertension
11/2021

Drug/Important Bio-Agent (IBA)

69Antiviral Agents (Antivirals)IBA
11/2022 - 10/2003
54Pharmaceutical PreparationsIBA
11/2022 - 02/2003
39InterferonsIBA
01/2022 - 03/2005
36RNA (Ribonucleic Acid)IBA
01/2022 - 05/2004
31Ribavirin (Virazole)FDA LinkGeneric
10/2020 - 07/2007
15SofosbuvirIBA
10/2021 - 08/2015
12Opioid Analgesics (Opioids)IBA
11/2022 - 07/2007
12VaccinesIBA
01/2022 - 03/2007
9velpatasvirIBA
10/2021 - 12/2015
8Alanine Transaminase (SGPT)IBA
01/2020 - 04/2007
7AntigensIBA
07/2021 - 01/2007
6glecaprevir and pibrentasvirIBA
01/2020 - 01/2017
6daclatasvirIBA
10/2019 - 02/2015
6peginterferon alfa-2a (Pegasys)FDA Link
02/2015 - 07/2007
5Protease Inhibitors (Protease Inhibitor)IBA
01/2017 - 11/2011
5Proteins (Proteins, Gene)FDA Link
05/2016 - 05/2000
5CytokinesIBA
02/2016 - 11/2012
5Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2014 - 06/2004
5Tenofovir (Viread)FDA Link
05/2013 - 01/2007
5Hepatitis B e AntigensIBA
01/2013 - 01/2007
4Interferon LambdaIBA
01/2022 - 11/2014
4telaprevirIBA
01/2016 - 11/2011
4Heroin (Diamorphine)IBA
10/2014 - 01/2014
3ombitasvirIBA
10/2020 - 11/2018
3dasabuvirIBA
10/2020 - 11/2018
3Ritonavir (Norvir)FDA Link
10/2020 - 11/2018
3paritaprevirIBA
10/2020 - 11/2018
3Biological ProductsIBA
01/2019 - 12/2013
3sofosbuvir drug combination ledipasvirIBA
01/2018 - 12/2016
3Interferon-gamma (Interferon, gamma)IBA
01/2016 - 01/2013
3Interferon-alpha (Interferon Alfa)IBA
10/2014 - 10/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2011 - 04/2008
3Lamivudine (Epivir)FDA Link
01/2010 - 01/2007
2sofosbuvir velpatasvir voxilaprevir drug combinationIBA
05/2022 - 01/2017
2Indicators and Reagents (Reagents)IBA
01/2022 - 11/2017
2Hepatitis C AntibodiesIBA
07/2021 - 10/2010
2elbasvirIBA
06/2020 - 11/2016
2grazoprevirIBA
06/2020 - 11/2016
2pibrentasvirIBA
01/2018 - 01/2017
2glecaprevirIBA
01/2018 - 01/2017
2NucleotidesIBA
01/2017 - 05/2016
2ChemokinesIBA
02/2016 - 01/2016
2LipidsIBA
01/2016 - 03/2010
2Transaminases (Aminotransferases)IBA
01/2016 - 12/2013
2Interleukin-6 (Interleukin 6)IBA
01/2016 - 09/2014
2EnzymesIBA
09/2014 - 11/2012
2N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
08/2014 - 11/2011
2SimeprevirIBA
08/2014 - 12/2013
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2014 - 06/2012
2RacivirIBA
01/2010 - 08/2009
1Immunoglobulin G (IgG)IBA
08/2022
1Buprenorphine (Subutex)FDA LinkGeneric
01/2022
1AntibodiesIBA
01/2021

Therapy/Procedure

92Therapeutics
11/2022 - 10/2003
16Opiate Substitution Treatment
01/2019 - 07/2005
9Highly Active Antiretroviral Therapy (HAART)
01/2013 - 04/2002
4Retreatment
11/2022 - 11/2017
4Liver Transplantation
11/2021 - 03/2005
4Duration of Therapy
12/2016 - 03/2011
2Injections
01/2022 - 01/2021
2Ambulatory Care (Outpatient Care)
01/2020 - 04/2011
2Drug Therapy (Chemotherapy)
10/2015 - 07/2007
2Tattooing
10/2010 - 09/2007
1Aftercare (After-Treatment)
01/2022